Innate Pharma
IPHA
#8372
Rank
ยฃ0.12 B
Marketcap
ยฃ1.48
Share price
7.26%
Change (1 day)
-27.24%
Change (1 year)

Earnings for Innate Pharma (IPHA)

Earnings in 2023: -ยฃ6.45 Million

According to Innate Pharma 's latest financial reports the company's current earnings are ยฃ57.37 Million. In 2023 the company made an earning of -ยฃ6.45 Million, an increase over its 2022 earnings that were of -ยฃ47.87 Million. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Innate Pharma from 2005 to 2023

Annual earnings

Year Earnings Change
2023-ยฃ6.45 Million-86.54%
2022-ยฃ47.87 Million20.74%
2021-ยฃ39.65 Million4951.09%
2020-ยฃ0.79 Million-111.57%
2019ยฃ6.78 M183.46%
2018ยฃ2.39 M-105.4%
2017-ยฃ44.35 Million-523.25%
2016ยฃ10.47 M-285.64%
2015-ยฃ5.65 Million-69.31%
2014-ยฃ18.4 Million498.29%
2013-ยฃ3.08 Million-5.62%
2012-ยฃ3.26 Million-53.32%
2011-ยฃ6.98 Million-50.1%
2010-ยฃ13.99 Million-13.3%
2009-ยฃ16.14 Million26.36%
2008-ยฃ12.77 Million27.35%
2007-ยฃ10.03 Million63.33%
2006-ยฃ6.14 Million9.81%
2005-ยฃ5.59 Million